<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR522.html">Part 522
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 522.1222  Ketamine.
                            </h3>
                            <p class="depth1"><em>(a)</em> Specifications. Each milliliter contains ketamine hydrochloride  equivalent to 100 milligrams (mg) ketamine base activity.</p><p class="depth1"><em>(b)</em> Sponsors. See Nos. 000859, 026637, 054628, 054771, 059399, and  063286 in Sec. 510.600(c) of this chapter.</p><p class="depth1"><em>(c)</em> Special considerations. Federal law restricts this drug to use  by or on the order of a licensed veterinarian.</p><p class="depth1"><em>(d)</em> Conditions of use--</p><p class="depth2"><em>(1)</em> Cats--</p><p class="depth3"><em>(i)</em> Amount. 5 to 15 mg/pound body  weight intramuscularly, depending on the effect desired.</p><p class="depth3"><em>(ii)</em> Indications for use. For restraint or as the sole anesthetic  agent in diagnostic or minor, brief surgical procedures that do not  require skeletal muscle relaxation.</p><p class="depth2"><em>(2)</em> Subhuman primates--</p><p class="depth3"><em>(i)</em> Amount. 3 to 15 mg/kilogram body weight  intramuscularly, depending upon the species, general condition, and age  of the subject.</p><p class="depth3"><em>(ii)</em> Indications for use. For restraint.  [67 FR 17283, Apr. 10, 2002, as amended at 73 FR 8192, Feb. 13, 2008.  Redesignated at 79 FR 16191, Mar. 25, 2014, as amended at 80 FR 13229,  Mar. 13, 2015]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
